Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Leone, Maurizio A ^a,b   Barizzone, Nadia ^b   Esposito, Federica ^c   Lucenti, Ausiliatrice ^a   Harbo, Hanne F ^d,e   Goris, An ^f   Kockum, Ingrid ^g   Oturai, Annette Bang ^h   Celius, Elisabeth Gulowsen ^d   Mero, Inger L ^d,e   Dubois, Bénédicte ^f   Olsson, Tomas ^g   Søndergaard, Helle Bach ^h   Cusi, Daniele ⁱ   Lupoli, Sara ⁱ   Andreassen, Bettina Kulle ^e   Barcellos, L ^k   Booth, D ^k   Comabella, M ^k   Compston, A ^k   D'Alfonso, Sandra ^b   De Jager, P ^k   Fontaine, B ^k   Hafler, D ^k   Haines, J ^k   Hauser, S L ^k   Hawkins, C ^k   Hemmer, B ^k   Hillert, J ^k   Ivinson, A ^k   Martin, R ^k   McCauley, J L ^k   Oksenberg, J ^k   Oturai, A ^k   Patsopoulos, N ^k   Pericak Vance, M ^k   Saarela, J ^k   Sawcer, S ^k   Spurkland, A ^k   Stewart, G ^k   Zipp, F ^k   Myhr, Kjell Morten ^k   Guerini, Franca R ^j   Naldi, Paola ^k   Galimberti, Daniela ^k   Scarpini, Elio ^k   Bergamaschi, Roberto ^k   Di Sapio, Antonella ^k   Caputo, Domenico ^k   Rosso, Gabriella ^k   Cordera, Susanna ^k   Cavalla, Paola ^k   Cavallo, Roberto ^k   Benedetti, Maria D ^k   Salvetti, Marco ^k   Capra, Ruggero ^k   Ghezzi, Angelo ^k   Annovazzi, Pietro ^k   Coniglio, Gabriella ^k   Liberatore, Giuseppe ^k   Rodegher, Mariaemma ^k   Moiola, Lucia ^k   Colombo, Bruno ^k   Radaelli, Marta ^k   Rossi, Paolo ^k   Martinelli, Vittorio ^k   Comi, Giancarlo ^c   Martinelli Boneschi, Filippo ^c,k   more..

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h Rigshospitalet   (Denmark)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR2 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 12P40; OLIGOCLONAL BAND;

ADULT; ALLELE; ARTICLE; BELGIAN; CEREBROSPINAL FLUID; CHROMOSOME 6Q; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK SCORE; GENETIC SUSCEPTIBILITY; GENOTYPE; HEALTH STATUS; HUMAN; IL12B GENE; ITALIAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; META ANALYSIS; MULTIPLE SCLEROSIS; PATHOGENESIS; RATING SCALE; SCANDINAVIAN; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879052306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064408     Document Type: Article

References (15)

1. Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, et al. (2012) The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler. 18: 974-982.
2. Balnyte R, Rastenyte D, Uloziene I, Mickevičiene D, Skordeniene E, et al. (2011) The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability. Medicina (Kaunas). 47: 368-73.
3. Romero-Pinel L, Martínez-Yélamos S, Bau L, Matas E, Gubieras L, et al. (2011) Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol. 18: 1258-62.
4. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 50: 121-127.
5. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, et al. (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology. 64: 1144-51.
6. Olsson T, Kostulas V, Link H, (1983) Improved detection of oligoclonal IgG cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin Chem 30: 1246-1249.
7. Bergamaschi L, Leone MA, Fasano ME, Guerini FR, Ferrante D, et al. (2010) HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun. 11: 173-80.
8. Dilthey AT, Moutsianas L, Leslie S, McVean G, (2011) HLA*IMP. An integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics. 27: 968-72.
9. The International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, Nature. 476: 214-219.
10. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, et al. (2009) Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 8: 1111-19.
11. Piwko W, Olma MH, Held M, Bianco JN, Pedrioli PG, et al. (2010) RNAi-based screening identifies the Mms22L-Nfkbil2 complex as a novel regulator of DNA replication in human cells. EMBO J. 29: 4210-22.
12. Dobson R, Ramagopalan S, Davis A, Giovannoni G (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. Published online on February 21, 2013 doi: 10.1136/jnnp-2012-304695.
13. Imrell K, Landtblom AM, Hillert J, Masterman T, (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology. 67: 1062-4.
14. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
15. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, et al. (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64: 1144-1151.